Home
›
Theravance Biopharma, Inc.
› SCHEDULE 13G/A Aug 14, 2026
Theravance Biopharma, Inc. (TBPH): SCHEDULE 13G/A filed Aug 14, 2026
Form type
SCHEDULE 13G/A
Filing date
Aug 14, 2026
Accession number
0001013594-26-000901
Filer
Theravance Biopharma, Inc.
(CIK 1583107)